Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy, Condition aggravated, Heart rate, Heart rate decreased, Rash
Clinical narrative: Heart Problems Low Heart Rate; tachycardia; Skin Rash; meaning it can flare up; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 11Feb2021 at 10:30 as dose 1, single (Lot number: EN6201) at the age of 50 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "sleep" (unspecified if ongoing); "contracted Covid", start date: Nov2020 (unspecified if ongoing), notes: He states he had contracted Covid in Nov2020. Concomitant medication(s) included: AMBIEN taken for sleep disorder; CANNABIDIOL taken for sleep disorder; TETRAHYDROCANNABINOLS NOS taken for sleep disorder. The following information was reported: CONDITION AGGRAVATED (non-serious) with onset Feb2021, 9 days 13 hrs 30 min after the suspect product(s) administration, outcome "unknown", described as "meaning it can flare up"; RASH (non-serious) with onset 21Feb2021, outcome "recovering", described as "Skin Rash"; HEART RATE DECREASED (hospitalization) with onset 15Mar2021, outcome "recovered" (Jun2022), described as "Heart Problems Low Heart Rate"; TACHYCARDIA (non-serious), outcome "unknown". The patient was hospitalized for heart rate decreased (start date: 02Apr2021, discharge date: 06Apr2021, hospitalization duration: 5 day(s)). The patient underwent the following laboratory tests and procedures: Biopsy: (unspecified date) inconclusive, notes: he has had 7 biopsies for the rash and they have all come back inconclusive; Heart rate: (unspecified date) drop to the 30s; (unspecified date) spike up to 130s; (unspecified date) low; SARS-CoV-2 test: (Nov2020) Unknown results, notes: he had contracted Covid in Nov2020. Therapeutic measures were taken as a result of heart rate decreased, rash, condition aggravated, tachycardia.  Clinical course:Caller reports he received his first vaccine on 11Feb2021, and a skin rash started shortly after, and then he developed heart problems and had to be in the hospital because he would have a low heart rate and then go to tachycardia. He states he had contracted Covid in Nov2020. Caller states he has been sick after the vaccine and going downhill since then. Caller reports within a 10 day period after the first vaccine the skin rash started. Caller states he was on Prednisone and that was the only thing that would clear the rash and he was on it for a year. Caller states he can't stand being on Prednisone all the time, so he just gets a Prednisone Injection if his skin flares up. He states currently it is improved, but it ebbs and flows, meaning it can flare up. He states it can be a little spot or he has had flare ups where his whole back becomes a big strawberry. He states the rash is on his back and the back of his legs. It started at his pants line above his buttock and then it spread to his upper back and then to the back of his legs. Caller reports he has had 7 biopsies for the rash and they have all come back inconclusive and the [Facility name withheld] did 3 of the biopsies. Caller states his heart rate would drop to the 30s and then spike up to 130s. He reports they were able to get it under control with Metoprolol. He states this was documented within the hospital environment. Caller states in Jul2022, he stopped taking Metoprolol. Prior Vaccinations (within 4 weeks) was reported as none. Patient's Medical History (including any illness at time of vaccination) was reported as none. Family Medical History Relevant to Adverse Events (AEs) was reported as none. Relevant Tests was reported as none.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201300369 same product, patient, different AEs, different dose.;US-PFIZER INC-202201300370 same product, patient, different AEs, different dose;